Ana-Belén Pérez (Ana Belén Pérez, Ana Belen Perez, Ana Belén Perez-Jimenez)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Venues

PloS one

Microbiology spectrum

Emerging microbes & infections

Microbial biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Casares-Jimenez, Diana Corona-Mata, Transito Garcia-Garcia, Leticia Manchado-Lopez, Lucia Rios-Muñoz, Maria de Guia-Castro, Pedro Lopez-Lopez, David Caceres-Anillo, Angela Camacho, Javier Caballero-Gomez, Ignacio Perez-Valero, Marina Gallo-Marin, Ana-Belén Pérez, Rainer G Ulrich, Antonio Rivero-Juarez, Antonio Rivero
Serological and molecular survey of rat hepatitis E virus ( Rocahepevirus ratti ) in drug users. Emerging microbes & infections (2024)
Ana-Belén Pérez, Marta Santos Bravo, Elisa Vidal-Verdú, Aurora Páez-Vega, José-Manuel Vaquero-Barrios, José-Luis Montero, Maria Ángeles Marcos, Julian Torre-Cisneros
Real-life experience in two cases of secondary prophylaxis with letermovir for CMV infection in solid organ transplantation. Microbiology spectrum (2023)
Pedro Lopez-Lopez, Mario Frias, Ana-Belén Pérez, Carolina Freyre-Carrillo, Juan A Pineda, Antonio Aguilera, Ana Fuentes, Juan Carlos Alados, Gabriel Reina, Encarnación Ramirez-Arellano, Isabel Viciana, Joao Mesquita, Javier Caballero-Gomez, Antonio Rivero, Antonio Rivero, null null
Optimization of the molecular diagnosis of the acute hepatitis E virus infection. Microbial biotechnology (2023)
Aurora Paez-Vega, Sara Cantisan, José Manuel Vaquero, Elisa Vidal, Antonio Luque-Pineda, María Ángeles Lobo-Acosta, Ana-Belén Pérez, Rodrigo Alonso-Moralejo, David Iturbe, Victor Monforte, Isabel Otero-Gonzalez, Amparo Pastor, Piedad Ussetti, Julian Torre-Cisneros
Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial. BMJ open 9 (8) (2019)
Ana-Belén Pérez, Natalia Chueca, Juan Macías, Juan Antonio Pineda, Javier Salmerón, Antonio Rivero-Juárez, Carmen Hidalgo-Tenorio, María Dolores Espinosa, Francisco Téllez, Miguel Ángel Von-Wichmann, Mohamed Omar, Jesús Santos, José Hernández-Quero, José Joaquin Antón, Antonio Collado, Ana Belén Lozano, Miguel García-Deltoro, Marta Casado, Juan Manuel Pascasio, Aida Selfa, José Miguel Rosales, Alberto De la Iglesia, Juan Ignacio Arenas, Silvia García-Bujalance, María José Ríos, Enrique Bernal, Onofre Martínez, Antonio García-Herola, Mónica Vélez, Pilar Rincón, Federico García
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort. PloS one 14 (8) (2019)
Lize Cuypers, Ana-Belén Pérez, Natalia Chueca, Teresa Aldamiz-Echevarría, Juan Carlos Alados Arboledas, Ana María Martínez-Sapiña, Dolores Merino, Juan Antonio Pineda, Francisco Téllez, Nuria Espinosa, Javier Salméron, Antonio Rivero-Juarez, María Jesús Vivancos, Víctor Hontañón, Anne-Mieke Vandamme, Féderico García
Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis. PloS one 13 (7) (2018)

Ana-Belén Pérez.css-eqlu8i{font-size:small;padding-left:4px;} (Ana Belén Pérez, Ana Belen Perez, Ana Belén Perez-Jimenez)

Publication Activity (10 Years)

Top Topics

Top Venues

Ana-Belén Pérez (Ana Belén Pérez, Ana Belen Perez, Ana Belén Perez-Jimenez)